Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Anyone experiencing memory problems or cognitive changes should consult their GP for appropriate investigation, which may include cognitive screening, blood tests, and neuroimaging as per NICE guidance (NG97)
Ascletis has announced the selection of ASC35, a best-in-class once-monthly subcutaneous GLP-1R/GIPR dual peptide agonist, advancing toward clinical development for obesity and metabolic diseases
When prescribing semaglutide, clinicians must consider several important gut health factors to ensure patient safety and optimize therapeutic outcomes
Diabetic retinopathy: more than meets the eye
E., & Katzinger, J
US$ 25.94
US$ 25.50
US$ 24.83
US$ 29.06
US$ 26.22
US$ 24.73
US$ 21.71
